Cargando…

Metabolomics reveals biomarkers in human urine and plasma to predict cytochrome P450 2D6 (CYP2D6) activity

BACKGROUND AND PURPOSE: Individualized assessment of cytochrome P450 2D6 (CYP2D6) activity is usually performed through phenotyping following administration of a probe drug to measure the enzyme's activity. To avoid any iatrogenic harm (allergic drug reaction, dosing error) related to the probe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Magliocco, Gaëlle, Desmeules, Jules, Matthey, Alain, Quirós‐Guerrero, Luis M., Bararpour, Nasim, Joye, Timothée, Marcourt, Laurence, Queiroz, Emerson F., Wolfender, Jean‐Luc, Gloor, Yvonne, Thomas, Aurélien, Daali, Youssef
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290485/ https://www.ncbi.nlm.nih.gov/pubmed/34363609 http://dx.doi.org/10.1111/bph.15651

Ejemplares similares

Evaluation of CYP1A2 activity: Relationship between the endogenous urinary 6‐hydroxymelatonin to melatonin ratio and paraxanthine to caffeine ratio in dried blood spots
por: Magliocco, Gaëlle, et al.
Publicado: (2022)

The 1β-Hydroxy-Deoxycholic Acid to Deoxycholic Acid Urinary Metabolic Ratio: Toward a Phenotyping of CYP3A Using an Endogenous Marker?
por: Magliocco, Gaëlle, et al.
Publicado: (2021)

Impact of Acute Inflammation on Cytochromes P450 Activity Assessed by the Geneva Cocktail
por: Lenoir, Camille, et al.
Publicado: (2021)

Impact of SARS‐CoV‐2 Infection (COVID‐19) on Cytochromes P450 Activity Assessed by the Geneva Cocktail
por: Lenoir, Camille, et al.
Publicado: (2021)

Physiologically‐Based Pharmacokinetic Modeling for the Prediction of CYP2D6‐Mediated Gene–Drug–Drug Interactions
por: Storelli, Flavia, et al.
Publicado: (2019)

Interaction between Fexofenadine and CYP Phenotyping Probe Drugs in Geneva Cocktail
por: Bosilkovska, Marija, et al.
Publicado: (2019)

Prediction of cytochromes P450 3A and 2C19 modulation by both inflammation and drug interactions using physiologically based pharmacokinetics
por: Lenoir, Camille, et al.
Publicado: (2021)

Cytochrome P(450) 2D6 polymorphism in eastern Indian population
por: Dhuya, Monalisa, et al.
Publicado: (2020)

Evaluation of Pupillometry for CYP2D6 Phenotyping in Children Treated with Tramadol
por: Rodieux, Frédérique, et al.
Publicado: (2023)

Influence of Inflammation on Cytochromes P450 Activity in Adults: A Systematic Review of the Literature
por: Lenoir, Camille, et al.
Publicado: (2021)

Impact of Inflammation on Cytochromes P450 Activity in Pediatrics: A Systematic Review
por: Lenoir, Camille, et al.
Publicado: (2021)

Geneva Cocktail for Cytochrome P450 and P-Glycoprotein Activity Assessment Using Dried Blood Spots
por: Bosilkovska, M, et al.
Publicado: (2014)

A longitudinal study of cytochrome P450 2D6 (CYP2D6) activity during adolescence
por: Leeder, J. Steven, et al.
Publicado: (2022)

Increased risk of hospitalization for ultrarapid metabolizers of cytochrome P450 2D6
por: Takahashi, Paul Y, et al.
Publicado: (2017)

Cytochrome P450-2D6 activity in people with codeine use disorder
por: Daglish, Mark R. C., et al.
Publicado: (2023)

Impacts of Cytochrome P450 2D6 (CYP2D6) Genetic Polymorphism in Tamoxifen Therapy for Breast Cancer
por: Bezerra, Lucas Soares, et al.
Publicado: (2018)

Reviewing Data Integrated for PBPK Model Development to Predict Metabolic Drug-Drug Interactions: Shifting Perspectives and Emerging Trends
por: Abouir, Kenza, et al.
Publicado: (2021)

Evaluation of cytochrome P450 2D6 phenotyping in healthy adult Western Indians
por: Gogtay, Nithya J., et al.
Publicado: (2014)

Genetic variants in the cytochrome P450 2D6 gene in the Sri Lankan population
por: Tharanga, T. D. Praveen, et al.
Publicado: (2013)

Role of cytochrome P450 2D6 genetic polymorphism in carvedilol hydroxylation in vitro
por: Wang, Zhe, et al.
Publicado: (2016)

Determination of Cytochrome P450 2D6 (CYP2D6) Gene Copy Number by Real-Time Quantitative PCR
por: Bodin, Laurent, et al.
Publicado: (2005)

Results and challenges of Cytochrome P450 2D6 (CYP2D6) testing in an ethnically diverse South Florida population
por: Salyakina, Daria, et al.
Publicado: (2019)

CYP450 Genotype—Phenotype Concordance Using the Geneva Micrococktail in a Clinical Setting
por: Ing Lorenzini, Kuntheavy, et al.
Publicado: (2021)

Association of Polymorphism in Cytochrome P450 2D6 and N-Acetyltransferase-2 with Parkinson’s Disease
por: Singh, Madhu, et al.
Publicado: (2010)

Rationalization of stereospecific binding of propranolol to cytochrome P450 2D6 by free energy calculations
por: Nagy, Gabor, et al.
Publicado: (2012)

A combinatorial approach for the discovery of cytochrome P450 2D6 inhibitors from nature
por: Hochleitner, Johannes, et al.
Publicado: (2017)

Cytochrome P450-2D6: A novel biomarker in liver cancer health disparity
por: Khamis, Zahraa I., et al.
Publicado: (2021)

Liquid Biopsy for Patient Characterization in Cardiovascular Disease: Verification against Markers of Cytochrome P450 and P‐Glycoprotein Activities
por: Achour, Brahim, et al.
Publicado: (2022)

Applications of CYP450 Testing in the Clinical Setting
por: Samer, C. F., et al.
Publicado: (2013)

Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection
por: Holdener, Martin, et al.
Publicado: (2008)

Systematic Functional Study of Cytochrome P450 2D6 Promoter Polymorphisms in the Chinese Han Population
por: Gong, Xueli, et al.
Publicado: (2013)

Determinants of Cytochrome P450 2D6 mRNA Levels in Healthy Human Liver Tissue
por: Ning, Miaoran, et al.
Publicado: (2019)

Influence of Cytochrome P450 2D6 Polymorphisms on the Efficacy of Oral Propranolol in Treating Infantile Hemangioma
por: Wang, Lidan, et al.
Publicado: (2020)

Influence of cytochrome P450 2D6 polymorphism on hippocampal white matter and treatment response in schizophrenia
por: Shin, Wonsuk, et al.
Publicado: (2021)

Cytochrome P450 2D6 genotype–phenotype characterization through population pharmacokinetic modeling of tedatioxetine
por: Frederiksen, Trine, et al.
Publicado: (2021)

Cytochrome P450 2C19 enzyme, Cytochrome P450 2C9 enzyme, and Cytochrome P450 2D6 enzyme allelic variants and its possible effect on drug metabolism: A retrospective study
por: Naujokaitis, Domas, et al.
Publicado: (2021)

Pharmacoresistant Severe Mental Health Disorders in Children and Adolescents: Functional Abnormalities of Cytochrome P450 2D6
por: Thümmler, Susanne, et al.
Publicado: (2018)

Spontaneous Ligand Access Events to Membrane-Bound Cytochrome P450 2D6 Sampled at Atomic Resolution
por: Fischer, André, et al.
Publicado: (2019)

An Investigation of O-Demethyl Tramadol/Tramadol Ratio for Cytochrome P450 2D6 Phenotyping: The CYTRAM Study
por: De La Gastine, Blandine, et al.
Publicado: (2022)

Prediction of Metabolic Interactions With Oxycodone via CYP2D6 and CYP3A Inhibition Using a Physiologically Based Pharmacokinetic Model
por: Marsousi, N, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_7sqfcr4ulhd80mtif8tbnemg69